Skip to content

Measuring of Neuro-visual Functionality With Ocusweep

Measuring of Neuro-visual Functionality With New Human Visual System Device Ocusweep

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02258113
Enrollment
600
Registered
2014-10-07
Start date
2014-11-30
Completion date
2022-12-31
Last updated
2020-06-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Visual Impairment

Brief summary

The aim of this study is to measure visual acuity, contrast sensitivity and visual field by SAP-method using a novel device Ocusweep compared to currently widely used methods. Addition to that, the aim is to validate a novel perimetry method (Visual Search Test, VST) which is based on reaction times in visual decision- making task, where the subject is allowed to move eyes and where the fixation is verified by the subject himself in contrast to standard automatic perimetry (SAP) where prolonged stationary fixation and external fixation monitoring apparatus is required. Reaction-time based visual field device Ocusweep is compared to generally used SAP methods. Those tests will be done for healthy volunteers and for persons with diagnosed eye or brain disease. Ocusweep OcuRT vision based choice reaction time test is validated for test repeatability and compared to Trail Making Test (TMT), Useful Field of View (UFOV) and Vienna Test System (VTS) reaction time tests. To evaluate the ability to detect unreliable results, OcuRT test is also done under cognitive load and with instructions to cheat the test.

Interventions

DEVICEOcusweep

A novel reaction-time based visual field device.

DEVICEOcusweep OcuRT

Vision based choice reaction time test method

Sponsors

Ocuspecto Oy
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 95 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy volunteers * Persons suffering diagnosed eye disease * Persons suffering diagnosed brain disease

Exclusion criteria

* No diabetes * Only one diagnosed disease

Design outcomes

Primary

MeasureTime frameDescription
Visual acuityOne visit per one patient (1h/visit)Visual acuity is measured as logMAR unit at the one visit for each patient using a novel reaction-time based visual field device and comparable method.

Secondary

MeasureTime frameDescription
Contrast sensitivityOne visit per one patient (1h/visit)Contrast sensitivity is measured as logCS unit at the one visit for each patient using a novel reaction-time based visual field device and comparable method.
Reaction time visual fieldOne visit per one patient (1h/visit)Reaction time is measured using a novel reaction-time based visual field device and compared with generally used visual field program.
Vision based choice reaction timeOne visit per one test subject (1h/visit)Reaction time is measured with Ocusweep OcuRT test three times to asses repeatability of the test. OcuRT reaction time results will be compared to Trail Making Test (TMT), Useful Field of View (UFOV) and Vienna Test System (VTS) reaction time tests. To evaluate the ability to detect unreliable results, OcuRT will also be done under cognitive load and with instructions to cheat the test.

Countries

Finland

Contacts

Primary ContactMarkku Leinonen, Dr
markku.leinonen@ocuspecto.com
Backup ContactJaakko Suominen, MSc
jaakko.suominen@ocuspecto.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026